Shengyu Cui

The progression of inorganic nanoparticles and natural products for inflammatory bowel disease

Ischemia-reperfusion injury: molecular mechanisms and therapeutic targets

miR‐145 attenuates cardiac fibrosis through the AKT/GSK‐3β/β‐catenin signaling pathway by directly targeting SOX9 in fibroblasts

Resveratrol alleviates the interleukin-1β-induced chondrocytes injury through the NF-κB signaling pathway